PT917471E - Tratamento e diagnostico de infeccoes por cocci gram-positivo - Google Patents

Tratamento e diagnostico de infeccoes por cocci gram-positivo

Info

Publication number
PT917471E
PT917471E PT97930642T PT97930642T PT917471E PT 917471 E PT917471 E PT 917471E PT 97930642 T PT97930642 T PT 97930642T PT 97930642 T PT97930642 T PT 97930642T PT 917471 E PT917471 E PT 917471E
Authority
PT
Portugal
Prior art keywords
diagnosis
methods
treatment
same
agents specific
Prior art date
Application number
PT97930642T
Other languages
English (en)
Inventor
Burnie James Peter
Matthews Ruth Christine
Original Assignee
Neutec Pharma Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neutec Pharma Plc filed Critical Neutec Pharma Plc
Publication of PT917471E publication Critical patent/PT917471E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/305—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F)
    • C07K14/31—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F) from Staphylococcus (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Cephalosporin Compounds (AREA)
PT97930642T 1996-07-06 1997-07-07 Tratamento e diagnostico de infeccoes por cocci gram-positivo PT917471E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9614274.0A GB9614274D0 (en) 1996-07-06 1996-07-06 Treatment and diagnosis of infections of gram positive cocci

Publications (1)

Publication Number Publication Date
PT917471E true PT917471E (pt) 2005-07-29

Family

ID=10796521

Family Applications (1)

Application Number Title Priority Date Filing Date
PT97930642T PT917471E (pt) 1996-07-06 1997-07-07 Tratamento e diagnostico de infeccoes por cocci gram-positivo

Country Status (13)

Country Link
US (2) US6544516B1 (pt)
EP (1) EP0917471B1 (pt)
JP (1) JP2001505534A (pt)
AT (1) ATE293456T1 (pt)
AU (1) AU717332B2 (pt)
CA (1) CA2259141C (pt)
DE (1) DE69733067T2 (pt)
DK (1) DK0917471T3 (pt)
ES (1) ES2238080T3 (pt)
GB (1) GB9614274D0 (pt)
NZ (1) NZ332991A (pt)
PT (1) PT917471E (pt)
WO (1) WO1998001154A2 (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6610293B1 (en) * 1997-06-16 2003-08-26 The Henry M. Jackson Foundation For The Advancement Of Military Medicine Opsonic and protective monoclonal and chimeric antibodies specific for lipoteichoic acid of gram positive bacteria
GB9806762D0 (en) * 1998-03-31 1998-05-27 Neutec Pharma Plc Treatment and diagnosis of staphylococcal infections
EP1624064A3 (en) * 1998-07-27 2006-05-10 Microbial Technics Limited Nucleic acids and proteins from streptococcus pneumoniae
EP1397502A2 (en) * 2001-01-17 2004-03-17 Avestha Gengraine Technologies PVT Ltd Dna sequencing of abc transporter or multi drug resistant protein for better environment stress tolerant crops
US6790448B2 (en) * 2001-05-08 2004-09-14 The Texas A&M University System University Surface proteins from gram-positive bacteria having highly conserved motifs and antibodies that recognize them
GB0127983D0 (en) * 2001-11-22 2002-01-16 Neutec Pharma Plc Treatment of micro-organism infection
US8729013B2 (en) 2004-08-26 2014-05-20 The University Of Western Ontario Methods of inhibiting staphylobactin-mediated iron uptake in S. aureus
EP2450053B1 (en) * 2010-11-05 2016-06-15 Universitätsklinikum Freiburg Novel antigen of enterococcal pathogens and use thereof as vaccine component for therapy and/or prophylaxis
EP2872535A1 (en) 2012-07-16 2015-05-20 Pfizer Inc. Saccharides and uses thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5747239A (en) * 1990-02-16 1998-05-05 United Biomedical, Inc. Synthetic peptides specific for the detection of antibodies to HCV, diagnosis of HCV infection and preventions thereof as vaccines
AU2679492A (en) * 1991-09-16 1993-04-27 Abbott Laboratories Hepatitis c assay
GB9401689D0 (en) * 1994-01-28 1994-03-23 Univ Manchester Diagnosis and treatment of endocarditis

Also Published As

Publication number Publication date
AU3452297A (en) 1998-02-02
DE69733067D1 (de) 2005-05-25
DK0917471T3 (da) 2005-06-06
WO1998001154A3 (en) 1998-06-25
WO1998001154A2 (en) 1998-01-15
CA2259141C (en) 2007-12-11
AU717332B2 (en) 2000-03-23
ES2238080T3 (es) 2005-08-16
US6544516B1 (en) 2003-04-08
GB9614274D0 (en) 1996-09-04
US20030119101A1 (en) 2003-06-26
EP0917471B1 (en) 2005-04-20
CA2259141A1 (en) 1998-01-15
JP2001505534A (ja) 2001-04-24
EP0917471A2 (en) 1999-05-26
US6881410B2 (en) 2005-04-19
DE69733067T2 (de) 2006-01-26
NZ332991A (en) 1999-06-29
ATE293456T1 (de) 2005-05-15

Similar Documents

Publication Publication Date Title
TR200102497T2 (tr) Yeni streptococcus antijenleri
UY26783A1 (es) Antígenos de estreptococo.
MXPA02011656A (es) Moleculas de acido nucleico nrg-2, polipeptidos, y metodos de diagnostico y terapeuticos.
AP2000001886A0 (en) Group B streptococcus antigens.
HUP0500345A2 (hu) Készítmények és alkalmazások tüdőrák kezelésére és diagnosztizálására
ATE461938T1 (de) Mit entzündlichen darmerkrankungen (ibd) assoziierte mikrobielle antigene und verfahren derer anwendung
NO20012812L (no) Vaksinesammensetning og vaksine samt anvendelse av polypeptid og polynukletid
CY1108765T1 (el) ΑΓΩΓΗ ME ΑΝΤΙΣΩΜΑΤΑ ANTI-ErbB2
EP1194164B8 (en) Prion protein peptides and uses thereof
WO1999051748A3 (en) Fusion proteins of mycobacterium tuberculosis antigens and their uses
CY1109868T1 (el) Cd81 πρωτεϊνη υποδοχεας ηπατιτιδας c
PT917471E (pt) Tratamento e diagnostico de infeccoes por cocci gram-positivo
GB9806762D0 (en) Treatment and diagnosis of staphylococcal infections
DE69714451D1 (de) Prionbindende proteine und deren verwendungen
WO2004003155A3 (en) Humanized anti-tag-72 cc49 for diagnosis and therapy of human tumors
IL159479A0 (en) Glycopeptides, their preparation and use in the diagnosis or therapeutic treatment of multiple sclerosis
WO2007118077A3 (en) Mycobacterial catalase-peroxidase in the diagnosis and treatment of sarcoidosis
GB9715177D0 (en) Medicament
EP1219635A3 (en) Chlamydia pneumoniae antigenes
EP1950302A3 (en) Streptococcus antigens
ATE490981T1 (de) Criptospezifische antikörper